New Delhi: Covaxin trial in the age group of 2-18 years has been cleared by the Drugs Controller General of India (DCGI) on Thursday. Bharat Biotech International Limited, Hyderabad had proposed to carry out the trial of the vaccine on the age group of 2-18 years.
In the phase Phase II/III clinical trial of the Covid vaccine will be carried out on 525 healthy volunteers by Bharat Biotech.
During the trial two vaccine doses will be injected by intramuscular route at day 0 and day 28. AIIMS (Delhi), AIIMS(Patna) and Meditrina Institute of Medical Sciences, Nagpur are the places for the trial.
Bhubaneswar: The Railways will temporarily augment several trains originating from Odisha with additional coaches to…
Bhubaneswar: The number of women reported missing in Odisha has risen steadily over the past…
Kakamigahara: India completed a perfect Pool A campaign at the Aichi-Nagoya Asian Games 2026 with…
Bhubaneswar: Odisha has reached a major milestone in its efforts to strengthen tsunami preparedness at…
Bhubaneswar: The Odisha government has ordered a comprehensive review of government land allotted or transferred…
Khordha: Traditional Paika martial arts took centre stage during the second Khordha Heritage Walks on…
